Oligodendroglioma screening: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
Sara Mohsin (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Oligodendroglioma}} | {{Oligodendroglioma}} | ||
{{CMG}}{{AE}}{{SR}} | {{CMG}}{{AE}}{{S.M.}}{{SR}} | ||
==Overview== | ==Overview== |
Revision as of 23:33, 29 April 2019
Oligodendroglioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oligodendroglioma screening On the Web |
American Roentgen Ray Society Images of Oligodendroglioma screening |
Risk calculators and risk factors for Oligodendroglioma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Sujit Routray, M.D. [3]
Overview
There is insufficient evidence to recommend routine screening for oligodendroglioma.[1]
Screening
There is insufficient evidence to recommend routine screening for oligodendroglioma.[1]
References
- ↑ 1.0 1.1 Early detection, diagnosis, and staging of brain tumors. American cancer society. http://www.cancer.org/cancer/braincnstumorsinadults/detailedguide/brain-and-spinal-cord-tumors-in-adults-detection